Neurocrine Biosciences Gross Profit 2006-2019 | NBIX

Neurocrine Biosciences annual/quarterly gross profit history and growth rate from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Neurocrine Biosciences gross profit for the quarter ending December 31, 2019 was $0.242B, a 85.87% increase year-over-year.
  • Neurocrine Biosciences gross profit for the twelve months ending December 31, 2019 was $0.781B, a 74.9% increase year-over-year.
  • Neurocrine Biosciences annual gross profit for 2019 was $0.781B, a 74.9% increase from 2018.
  • Neurocrine Biosciences annual gross profit for 2018 was $0.446B, a 178.32% increase from 2017.
  • Neurocrine Biosciences annual gross profit for 2017 was $0.16B, a 969.15% increase from 2016.
Neurocrine Biosciences Annual Gross Profit
(Millions of US $)
2019 $781
2018 $446
2017 $160
2016 $15
2015 $20
2014 $
2013 $3
2012 $53
2011 $77
2010 $34
2009 $3
2008 $4
2007 $1
2006 $39
2005 $124
Neurocrine Biosciences Quarterly Gross Profit
(Millions of US $)
Q4 2019 $242
Q3 2019 $220
Q2 2019 $182
Q1 2019 $137
Q4 2018 $130
Q3 2018 $150
Q2 2018 $96
Q1 2018 $70
Q4 2017 $94
Q3 2017 $60
Q2 2017 $6
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016 $15
Q4 2015
Q3 2015
Q2 2015
Q1 2015 $20
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013 $1
Q3 2013 $1
Q2 2013 $1
Q1 2013 $1
Q4 2012 $22
Q3 2012 $9
Q2 2012 $11
Q1 2012 $11
Q4 2011 $11
Q3 2011 $42
Q2 2011 $12
Q1 2011 $13
Q4 2010 $14
Q3 2010 $14
Q2 2010 $5
Q1 2010 $1
Q4 2009 $1
Q3 2009 $1
Q2 2009 $1
Q1 2009 $1
Q4 2008 $1
Q3 2008 $1
Q2 2008 $1
Q1 2008 $2
Q4 2007 $1
Q3 2007 $1
Q2 2007 $0
Q1 2007 $0
Q4 2006 $9
Q3 2006 $1
Q2 2006 $9
Q1 2006 $19
Q4 2005 $14
Q3 2005 $65
Q2 2005 $33
Q1 2005 $12
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.486B $0.788B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $63.617B 36.80
Takeda Pharmaceutical (TAK) Japan $54.955B 9.74
Astellas Pharma (ALPMY) Japan $29.466B 14.72
Eisai (ESALY) Japan $21.073B 40.62
UCB SA (UCBJF) Belgium $18.905B 0.00
Grifols, S.A (GRFS) Spain $16.144B 21.15
Merck (MKGAF) Germany $15.852B 21.63
Ono Pharmaceutical (OPHLF) Japan $11.311B 24.18
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $7.680B 31.60
Ionis Pharmaceuticals (IONS) United States $7.496B 22.49
Jazz Pharmaceuticals (JAZZ) Ireland $6.349B 7.74
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
IPSEN SA ADR (IPSEY) France $5.641B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $4.584B 13.94
United Therapeutics (UTHR) United States $4.423B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.660B 67.93
Evotec AG (EVTCY) Germany $3.643B 58.78
Nektar Therapeutics (NKTR) United States $3.612B 0.00
FibroGen (FGEN) United States $3.539B 104.00
PTC Therapeutics (PTCT) United States $3.300B 0.00
Sage Therapeutics (SAGE) United States $2.695B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.675B 10.82
ChemoCentryx (CCXI) United States $2.565B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.955B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.883B 22.89
Xencor (XNCR) United States $1.833B 74.86
Pacira Pharmaceuticals (PCRX) United States $1.800B 49.22
Heron Therapeutics (HRTX) United States $1.615B 0.00
Corcept Therapeutics (CORT) United States $1.529B 17.10
Tilray (TLRY) Canada $1.461B 0.00
Esperion Therapeutics (ESPR) United States $1.429B 0.00
USANA Health Sciences (USNA) United States $1.402B 14.72
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.358B 0.00
Endo (ENDP) Ireland $1.277B 2.36
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.134B 15.79
Zogenix (ZGNX) United States $1.048B 0.00
Karyopharm Therapeutics (KPTI) United States $1.008B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.993B 30.75
Akebia Therapeutics (AKBA) United States $0.987B 0.00
Radius Health (RDUS) United States $0.911B 0.00
Portola Pharmaceuticals (PTLA) United States $0.791B 0.00
Aerie Pharmaceuticals (AERI) United States $0.790B 0.00
Collegium Pharmaceutical (COLL) United States $0.727B 0.00
ImmunoGen (IMGN) United States $0.657B 0.00
Flexion Therapeutics (FLXN) United States $0.592B 0.00
Molecular Templates (MTEM) United States $0.579B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.511B 0.00
TherapeuticsMD (TXMD) United States $0.451B 0.00
Ardelyx (ARDX) United States $0.440B 0.00
Translate Bio (TBIO) United States $0.435B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.431B 52.25
BioSpecifics Technologies Corp (BSTC) United States $0.426B 18.35
Innate Pharma SA (IPHYF) France $0.423B 0.00
Indivior (INVVY) United States $0.417B 2.48
BioCryst Pharmaceuticals (BCRX) United States $0.407B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.382B 0.00
Siga Technologies (SIGA) United States $0.375B 8.57
Organogenesis Holdings (ORGO) United States $0.370B 0.00
Calithera Biosciences (CALA) United States $0.357B 0.00
Lannett Co Inc (LCI) United States $0.353B 5.69
Harpoon Therapeutics (HARP) United States $0.350B 0.00
DURECT (DRRX) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 0.00
Recro Pharma (REPH) United States $0.337B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.326B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.314B 0.00
Rafael Holdings (RFL) United States $0.311B 0.00
Concert Pharmaceuticals (CNCE) United States $0.301B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.271B 0.00
OptiNose (OPTN) United States $0.268B 0.00
KalVista Pharmaceuticals (KALV) United States $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.221B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
MEI Pharma (MEIP) United States $0.212B 0.00
Taiwan Liposome (TLC) Taiwan $0.185B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.183B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.178B 30.73
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
Jounce Therapeutics (JNCE) United States $0.151B 2.79
IMV INC (IMV) Canada $0.122B 0.00
VAXART, INC (VXRT) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.110B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.098B 0.00
Xeris Pharmaceuticals (XERS) United States $0.097B 0.00
CannTrust Holdings (CTST) Canada $0.095B 0.00
Otonomy (OTIC) United States $0.093B 0.00
Aquestive Therapeutics (AQST) United States $0.089B 0.00
Redhill Biopharma (RDHL) Israel $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.085B 0.00
Generex Biotechnology (GNBT) United States $0.082B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
Onconova Therapeutics (ONTX) United States $0.065B 0.00
MediWound (MDWD) Israel $0.065B 0.00
CV Sciences (CVSI) United States $0.065B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 18.64
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
Nivalis Therapeutics (ALPN) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
IsoRay (ISR) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.051B 23.13
AgeX Therapeutics (AGE) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Aclaris Therapeutics (ACRS) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
PolarityTE (PTE) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.028B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
ElectroCore (ECOR) United States $0.023B 0.00
Vical (BBI) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Cardiome Pharma (CORV) Canada $0.017B 0.00
Shineco (TYHT) China $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 0.00
Hemispherx BioPharma (AIM) United States $0.014B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Novan (NOVN) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00